Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jan 29;219(4):672-673.
doi: 10.1093/infdis/jiy557.

Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS

Affiliations
Comment

Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS

Amitabh B Suthar et al. J Infect Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Comment in

  • Reply to Suthar et al.
    Wallis CL, Godfrey C, Fitzgibbon JE, Mellors JW. Wallis CL, et al. J Infect Dis. 2019 Jan 29;219(4):673-674. doi: 10.1093/infdis/jiy558. J Infect Dis. 2019. PMID: 30307562 Free PMC article. No abstract available.

Comment on

References

    1. Wallis CL, Godfrey C, Fitzgibbon JE, Mellors JW. Key factors influencing the emergence of human immunodeficiency virus drug resistance in low- and middle-income countries. J Infect Dis 2017; 216:851–6. - PMC - PubMed
    1. World Health Organization. A study on the public health and socioeconomic impact of substandard and falsified medical products, 2017. http://www.who.int/entity/medicines/regulation/ssffc/publications/Layout.... Accessed 23 April 2018.
    1. Zoufaly A, Jochum J, Hammerl R, et al. Determinants of HIV-1 drug resistance in treatment-naïve patients and its clinical implications in an antiretroviral treatment program in Cameroon. J Int AIDS Soc 2014; 17:19615. - PMC - PubMed
    1. Ahoua L, Guenther G, Pinoges L, et al. Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. BMC Infect Dis 2009; 9:81. - PMC - PubMed
    1. Global Burden of Disease Health Financing Collaborator Network. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015. Lancet 2018; 391:1799–829. - PMC - PubMed